MarketFriction

Poly Medicure Ltd

NSE POLYMED · BSE 531768 · Medical Equipment & Supplies
₹1,638.10 -2.13%
NSE close2026-10-01
52 week range1,182.00 - 2,094.30
Market cap₹16,671 Cr.
P/E52.1
Nifty 500Smallcap 250 Price band 20% Delivery 46.1%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales337340378385420424441403444494535525
Expenses253249282281305310321298329382424400
Operating Profit849096104115114119106115111110125
OPM %25%27%26%27%27%27%27%26%26%23%21%24%
Other Income151715172724274335211935
Interest233333233666
Depreciation161616202121212325293836
Profit before tax818892981181131231231229885117
Tax %23%26%26%25%26%25%25%24%25%27%24%27%
Net Profit626568748785929392716585
EPS in Rs6.486.787.127.718.638.419.069.199.067.006.548.49
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4114545196106877859221,1151,3751,6691,8751,997
Expenses3233613974795205697078471,0141,2131,4291,536
Operating Profit8893122131166216215267361456446461
OPM %21%21%23%22%24%28%23%24%26%27%24%23%
Other Income8141620212240386094119110
Interest1081214201161114142122
Depreciation21242937414854576383116128
Profit before tax657597100126180195237344453427422
Tax %27%27%27%35%24%25%25%25%25%25%25%
Net Profit4855716596136147179258339321313
EPS in Rs5.476.258.007.4110.8614.1715.2818.6926.9133.4131.7831.09
Dividend Payout %27%40%25%27%18%18%16%16%11%10%11%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth16%19%19%18%
Compounded Profit Growth19%14%15%-11%
Stock Price CAGR24%12%6%-16%
Return on Equity15%13%13%9%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital222244444444484848485151
Reserves1742072272943373919181,0401,1941,4222,7153,055
Borrowings7982101133161207137127149174180354
Other Liabilities89768594112126121163187215246401
Total Liabilities3643874575656547671,2241,3771,5771,8593,1923,861
Fixed Assets1651822072653063634264886358671,0841,694
CWIP1014201819252143787610199
Investments443178253543461261671,076755
Other Assets1851872272643213544224997387489301,313
Total Assets3643874575656547671,2241,3771,5771,8593,1923,861
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity63635675106131119123191266233246
Cash from Investing Activity-59-31-56-88-101-109-436-85-179-241-1,187-224
Cash from Financing Activity-6-31-016-5-21317-35-13-2095120
Net Cash Flow-21031103-15-343
Free Cash Flow1331-0-7312524-31-48-9-97-59
CFO/OP101%88%79%80%102%100%75%80%93%94%71%78%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days5974777977687282777276103
Inventory Days148114194161186241217218237205233323
Days Payable1017613196123142111115105897091
Cash Conversion Cycle106111140144139166179185209188239335
Working Capital Days2535557156427481695475105
ROCE %30%26%24%26%22%25%22%17%18%24%18%12%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters53.17%53.17%53.14%66.02%62.56%62.44%62.44%62.44%62.42%62.42%62.42%62.42%
FIIs14.49%14.10%12.37%9.91%11.88%12.33%11.46%11.41%9.77%9.41%5.92%5.56%
DIIs5.15%5.46%7.21%9.34%12.33%11.66%11.96%11.72%13.53%13.84%15.60%16.08%
Public27.20%27.28%27.25%14.72%13.23%13.57%14.13%14.43%14.28%14.34%16.08%15.94%
No. of Shareholders34,64936,05336,71236,85238,35260,68665,58371,14264,40067,75073,41473,643

Fundamentals

Market Cap₹ 16,671 Cr.
Current Price₹ 1,645
Stock P/E52.1
Book Value₹ 306
ROCE12.5 %
ROE9.02 %
Dividend Yield0.21 %
Face Value₹ 5.00
Compounded Sales Growth (TTM)18%
Compounded Profit Growth (TTM)-11%
Consolidated figures.
Valuation
Market capRs 16,604 Cr
Enterprise valueRs 16,869 Cr
P/E (TTM)52.70x
Price to book5.35x
Price to sales8.31x
EV / EBITDA29.50x
EV / EBIT38.02x
EV / sales8.45x
Price to cash flow67.39x
Earnings yield1.90%
Dividend yield0.21%
P/E, 3-year average54.58x
P/B, 3-year average7.50x
P/E, 5-year average55.37x
P/B, 5-year average7.64x
Profitability
Operating margin (excl. other income)23.77%
Operating margin (incl. other income)30.11%
EBITDA margin28.63%
Pre-tax margin21.12%
Net profit margin15.77%
Net margin, latest quarter16.37%
ROE10.97%
ROCE14.02%
ROA9.14%
ROE, 3-year average15.34%
ROCE, 3-year average19.31%
ROA, 3-year average12.52%
ROE, 5-year average15.13%
ROCE, 5-year average18.88%
ROA, 5-year average12.20%
ROIC (approx.)9.87%
Tax rate24.97%
Other income / net worth3.82%
Growth
Sales growth (latest year)12.31%
Profit growth (latest year)-4.85%
Sales CAGR, 3 years18.91%
Sales CAGR, 5 years19.01%
Profit CAGR, 3 years21.57%
Profit CAGR, 5 years18.85%
Sales growth QoQ-1.71%
Profit growth QoQ29.78%
Sales growth YoY (latest quarter)30.30%
Profit growth YoY (latest quarter)-7.57%
Per share
EPS (TTM)Rs 31.09
EPS (latest year)Rs 31.78
EPS (latest quarter)Rs 8.49
EPS, 3-year averageRs 30.70
EPS, 5-year averageRs 25.21
Book value per shareRs 306.45
Sales per shareRs 197.06
Cash flow per shareRs 24.31
Free cash flow per shareRs -5.82
Dividend per share (latest year)Rs 3.50
Dividend per share, 3-year averageRs 3.33
Dividend per share, 5-year averageRs 3.10
Dividends
Dividend payout11.01%
Dividend payout, 3-year average10.88%
Dividend payout, 5-year average13.01%
Efficiency
Asset turnover0.49x
Fixed asset turnover1.11x
Inventory turnover1.90x
Inventory days193 days
Debtor days103 days
Debtors turnover3.53x
Creditor days91 days
Cash conversion cycle335 days
Working capital days105 days
Leverage
Total debtRs 354 Cr
Cash and bankRs 88 Cr
Net debtRs 266 Cr
Debt to equity0.11x
Net debt / EBITDA0.46x
Interest coverage20.31x
Current ratio (filing 2026-03-31)3.37x
Quick ratio (filing 2026-03-31)2.62x
Trade payables (filing 2026-03-31)Rs 123 Cr
Owners' fund to total sources80.46%
Debt to assets9.16%
Cash flow
Cash from Operating Activity (latest year)Rs 246 Cr
Cash from Investing Activity (latest year)Rs -224 Cr
Cash from Financing Activity (latest year)Rs 20 Cr
Net Cash Flow (latest year)Rs 43 Cr
Free cash flow (latest year)Rs -59 Cr
FCFE (approx.: FCF + change in debt)Rs 114 Cr
Cash from ops / profit, 5 years0.85x
Sales to cash flow7.61x
Statement figures
Net sales (TTM)Rs 1,997 Cr
Net sales (latest year)Rs 1,875 Cr
Sales (latest quarter)Rs 525 Cr
Operating profit excl. other income (latest year)Rs 446 Cr
Operating profit (latest quarter)Rs 125 Cr
Other income (TTM)Rs 110 Cr
EBITDA (TTM)Rs 572 Cr
PBDT (TTM)Rs 550 Cr
Profit before tax (TTM)Rs 422 Cr
Tax (latest year)Rs 107 Cr
Net profit (TTM)Rs 315 Cr
Net profit (latest year)Rs 322 Cr
Net profit (latest quarter)Rs 86 Cr
Depreciation (TTM)Rs 128 Cr
Depreciation (latest quarter)Rs 36 Cr
Interest (TTM)Rs 22 Cr
Cost of goods sold (latest year)Rs 823 Cr
Total expenditure (latest year)Rs 1,429 Cr
Total income (latest year)Rs 1,993 Cr
Share capitalRs 51 Cr
ReservesRs 3,055 Cr
Shareholders' fundsRs 3,106 Cr
Total assetsRs 3,861 Cr
Net blockRs 1,694 Cr
Capital work in progressRs 99 Cr
InvestmentsRs 755 Cr
ReceivablesRs 531 Cr
InventoryRs 434 Cr
Other liabilitiesRs 401 Cr
Shares outstanding (crore)10.14
Ownership
Promoter holding62.42% (-0.02 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 52.7 is at the 44th percentile of its own 9.4-year range (median 54.3, low 27.1, high 112.8).
P/B 5.35 is at the 5th percentile (median 8.73).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodPOLYMEDNifty 50Difference
1 week-4.5%-2.8% -1.8 pts
1 month-6.7%-6.8% +0.1 pts
3 months-2.4%-7.6% +5.3 pts
6 months+37.5%+0.4% +37.1 pts
1 year-19.4%-9.9% -9.5 pts
2 years-30.6%-13.6% -17.0 pts
3 years+19.2%+14.2% +5.0 pts
5 years+75.1%+27.9% +47.2 pts
63 mutual fund schemes hold about ₹1,758 Cr. Over three months 26 bought more and 7 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Quant Small Cap Fund2.16%767 -2%
UTI Flexi Cap Fund1.00%243 -1%
HSBC Midcap Fund1.26%217 +53%
SBI Healthcare Opp Fund1.94%113 -8%
SBI MNC Fund1.47%99 +0%
WOC Flexi Cap Fund0.61%55 -4%
Quant Multi Cap Fund0.60%47 +7%
Invesco India Largecap Fund1.51%31 -2%
WOC Mid Cap Fund0.36%27 -12%
WOC Multi Cap Fund0.59%24 -6%
UTI ULIP 10Y0.45%23 +5%
Nippon India Nifty Smallcap 250 Index Fund0.30%11 +3%
WOC Large & Mid Cap Fund0.41%10 -2%
WOC Multi Asset Allocation Fund0.10%9 -6%
WOC Quality Equity Fund1.34%8 +7%
WOC Balanced Advantage Fund0.32%7 +2%
WOC Pharma and Healthcare Fund0.76%7 -23%
Qsif Equity Ex-Top 100 Long-Short Fund1.57%7 +100%
SBI Nifty Smallcap 250 Index Fund0.30%5 +3%
DSP Nifty Smallcap250 Quality 50 Index Fund1.59%5 +4%
WOC Large Cap Fund0.39%5 +1%
ITI Pharma & Healthcare Fund1.50%4 +20%
Motilal Oswal Nifty Smallcap 250 Index Fund0.30%4 +3%
WOC ELSS Tax Saver Fund0.73%4 -0%
Invesco India Equity Savings Fund1.13%3 +12%

Red flags

F-score 3 of 8
explainReceivables outrunning sales Receivables grew 52% vs sales +12% in 2026
explainDebt up, profit down Borrowings up 96% while net profit fell in 2026
lookInventory outrunning sales Inventory grew 52% vs sales +12% in 2026
lookRegulator order or action Regulator order or action 2026-06-16: Poly Medicure Limited has informed the Exchange about Action(s) taken or orders passed on receipt Of An Order Passed By Office of Divisional
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹525 Cr +30.3% vs Jun 2025. Net profit ₹85 Cr -8.6%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Molbio Diagnostics Ltd14,47066.618.0 %
Fischer Medical Ventures Ltd2,35596.211.4 %
Tarsons Products Ltd1,7541484.59 %
Q-Line Biotech Ltd1,56927.822.5 %
Laxmi Dental Ltd1,05830.415.0 %
Hemant Surgical Industries Ltd86951.318.9 %
Vasa Denticity Ltd75462.37.54 %
OSEL Devices Ltd69123.624.4 %
Prevest Denpro Ltd46220.524.9 %
QMS Medical Allied Services Ltd41939.012.9 %
Nureca Ltd34980.43.30 %
Aprameya Engineering Ltd20039.712.6 %
Avience Biomedicals Ltd19822.727.0 %
Earkart Limited17936.317.5 %
Vaidya Sane Ayurved Laboratories Ltd17619.615.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-08-28Dividend - Rs 3.50 Per Share
2025-09-18Dividend - Rs 3.50 Per Share
2024-09-19Annual General Meeting/Dividend - Rs 3 Per Share
2023-09-21Annual General Meeting/Dividend - Rs 3 Per Share
2022-09-16Annual General Meeting/Dividend - Rs 2.50 Per Share
2021-09-16 Dividend - Rs 2.50 Per Share
2021-09-16 Annual General Meeting
2020-09-21 Annual General Meeting
2020-02-27 Interim Dividend - Rs 2 Per Share
2019-09-13 Annual General Meeting/Dividend - Rs 2 Per Share
2018-09-18 Annual General Meeting/Dividend- Rs 2 Per Share (Purpose Revised)
2017-09-20 Dividend- Re 0.50 Per Share
2017-09-20 Annual General Meeting/Dividend - Re 0.50 Per Share
2017-03-24 Bonus 1:10.5000
2017-02-15 Interim Dividend Re 1/- Per Share
2016-11-11 Interim Dividend Re 1/- Per Share (Purpose Revised)
2016-09-19 Annual General Meeting/Dividend - Re 0.50 Per Share (Purpose Revised)
2016-03-17 Interim Dividend - Rs 2.50/- Per Share (Purpose Revised)
2015-09-18 Annual General Meeting/Dividend Rs 2.50 Per Share
2015-02-02Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 5/- Per Share0.5000
2014-09-15Annual General Meeting / Dividend - Rs 4/- Per Share
2013-09-19Annual General Meeting / Dividend Rs.2 Per Share
2013-07-09Bonus 1:10.5000
2012-09-13Annual General Meeting/ Dividend Rs.3 Per Share
DateTypeWhat it says
2026-09-24General UpdatesIntimation For The Schedule Of Investors/Analysts Call/Meet.
2026-09-23General UpdatesGeneral Updates
2026-09-21General UpdatesGeneral Updates
2026-09-18General UpdatesGeneral Updates
2026-09-07Shareholder meetingVoting results.
2026-09-05Shareholder meetingProceedings of Annual General Meeting held on September 05, 2026
2026-09-02General UpdatesGeneral Updates
2026-08-25General UpdatesPOLYMED: Intimation On Rescheduling Of Investor/Analyst Meet
2026-08-22General UpdatesIntimation for the schedule of Investors/Analyst Call/ Meet.
2026-08-20General UpdatesInvestor Call Scheedule to be held on 20th August, 2026 is Cancelled
2026-08-17General UpdatesThe schedule of Investors/Analysts Call/Meet
2026-08-14Concall / analyst meetTranscript
2026-08-14General UpdatesGeneral Updates
2026-08-14Record DateRecord date for the purpose of Dividend is 29-Aug-2026.
2026-08-14General UpdatesGeneral Updates
2026-08-14Shareholder meetingShareholders meeting
2026-08-10Concall / analyst meetLink of Recording
2026-08-10Statement of deviation(s) orStatement of deviation(s) or variation(s) under Reg. 32
2026-08-10Monitoring Agency ReportMonitoring Agency Report for the quarter ended 30th June, 2026
2026-08-08ResignationResignation of Director/KMP/SMP
2026-08-07Investor PresentationInvestor Presentation
2026-08-07ResignationResignation of Ravi Prakash, Deputy Company Secretary as KMP of the company w.e.f. August 10, 2026.
2026-08-07ESOPGrant of 1476 Options under ESOP Scheme, 2020
2026-08-07ESOPAllotment of 1975 Shares under ESOP Scheme , 2020
2026-08-07Board meeting outcomePoly Medicure Limited has informed the outcome of Board Meeting held on today i.e. 07th August, 2026 and submitted to the Exchange, the financial resu...
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Poly Medicure Ltd?

Poly Medicure Ltd (POLYMED) has a market capitalisation of Rs 16,671 Cr. at the 2026-10-01 close.

What is the P/E ratio of Poly Medicure Ltd?

Poly Medicure Ltd trades at a P/E of 52.1 on trailing twelve-month profit, at the 2026-10-01 close.

What were Poly Medicure Ltd's latest quarterly results?

In the Jun 2026 quarter, Poly Medicure Ltd sales was Rs 525 Cr (+30.3% vs Jun 2025) and net profit was Rs 85 Cr.

What is the 52-week high and low of Poly Medicure Ltd?

The 52-week high is Rs 2,094.30 and the 52-week low is Rs 1,182.00.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03